Sunday, 24 October 2021

Australia's most trusted
source of pharma news

Sunday, 24 October 2021

Gilead exec near death after vax

Alyssa Kent at her 40th birthday

Posted 9 July 2021 AM

The Australian pharma industry has rallied to support Gilead senior business unit director Alyssa Kent who suffered a blood clot to the brain after having the AstraZeneca COVID-19 vaccine, leaving her in a coma for two weeks and close to death.

The popular 40-year-old married mother of two spent three weeks in ICU, with her family forced to make "end of life choices" three times.

To see the whole article, please login

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read. If you don't have a password, simply enter your email address.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.